NEXGEL, Inc. (NXGL) Financial Ratios
9 years of historical data (2016–2024) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
0.64
↓-72% vs avg
5yr avg: 2.31
30Y Low0.9·High4.8
ROE
↑
-58.3%
↓+76% vs avg
5yr avg: -246.1%
30Y Low-417%·High-48%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
NXGL Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
NEXGEL, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5M | $29M | $12M | $7M | $15M | — | — | — | — | — |
| Enterprise Value | $6M | $30M | $12M | $8M | $5M | — | — | — | — | — |
| P/E Ratio → | -1.19 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.56 | 3.34 | 2.95 | 3.40 | 9.38 | — | — | — | — | — |
| P/B Ratio | 0.64 | 4.78 | 2.34 | 0.91 | 1.20 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
NXGL EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.46 | 2.98 | 3.88 | 3.52 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — |
NXGL Profitability
Margins and return-on-capital ratios measuring operating efficiency
NEXGEL, Inc. earns an operating margin of -40.9%. Operating margins have expanded from -163.5% to -40.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -58.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.6% | 31.6% | 9.1% | 12.5% | 0.5% | -43.2% | -19.1% | 23.2% | 7.4% | -5.3% |
| Operating Margin | -40.9% | -40.9% | -85.0% | -163.5% | -165.7% | -335.3% | -268.3% | -85.3% | -48.6% | -86.6% |
| Net Profit Margin | -37.8% | -37.8% | -77.2% | -231.7% | -277.9% | -335.9% | -268.2% | -85.3% | -47.8% | -82.5% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -58.3% | -58.3% | -49.3% | -48.1% | -70.9% | -1004.0% | -581.8% | -416.8% | -134.3% | -223.7% |
| ROA | -31.3% | -31.3% | -31.1% | -34.7% | -44.8% | -109.2% | -146.3% | -231.2% | -88.4% | -140.8% |
| ROIC | -43.1% | -43.1% | -37.6% | -43.2% | -89.3% | -144.1% | -219.1% | -312.6% | -102.4% | -176.1% |
| ROCE | -44.7% | -44.7% | -41.1% | -28.4% | -34.2% | -224.3% | -270.6% | -371.7% | -124.2% | -212.5% |
NXGL Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $1M ($3M total debt minus $2M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.46 | 0.46 | 0.54 | 0.27 | 0.35 | 17.99 | 2.41 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.17 | 0.02 | 0.13 | -0.75 | 17.54 | 1.73 | 0.00 | 0.00 | 0.00 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -43.88 | -43.88 | -231.80 | -2.51 | -1.29 | -226.00 | — | — | — | — |
NXGL Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
NEXGEL, Inc.'s current ratio of 2.07x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.36x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 8.74x to 2.07x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.07 | 2.07 | 1.98 | 8.74 | 4.82 | 0.27 | 0.64 | 0.89 | 0.95 | 0.67 |
| Quick Ratio | 1.36 | 1.36 | 1.46 | 8.15 | 4.72 | 0.10 | 0.50 | 0.64 | 0.50 | 0.26 |
| Cash Ratio | 0.73 | 0.73 | 1.06 | 7.69 | 4.62 | 0.02 | 0.33 | — | — | — |
| Asset Turnover | — | 0.79 | 0.41 | 0.20 | 0.09 | 0.30 | 0.38 | 2.99 | 2.23 | 1.71 |
| Inventory Turnover | 3.39 | 3.39 | 2.82 | 3.57 | 5.30 | 4.14 | 7.56 | 16.82 | 19.84 | 14.34 |
| Days Sales Outstanding | — | 39.20 | 56.50 | 39.57 | 49.18 | 39.53 | 51.92 | 5.61 | 18.14 | 12.55 |
NXGL Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
NEXGEL, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M |
Peer Comparison
Compare NXGL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 NXGLYou | $5M | -1.2 | — | — | 31.6% | -40.9% | -58.3% | -43.1% | — |
 LIQT | $22M | -2.6 | — | — | 7.6% | -50.3% | -63.1% | -31.1% | — |
 XTLB | $279464 | -0.3 | — | — | 0.7% | -481.6% | -26.8% | -54.1% | — |
 BFRI | $13M | — | — | — | 75.8% | -27.2% | -141.3% | -124.3% | — |
 SKIN | $75M | -3.6 | 48.6 | 2.0 | 65.3% | -6.9% | -16.9% | -6.8% | 83.3 |
 DERM | $104M | -7.0 | — | — | 62.8% | -24.4% | -72.6% | -56.8% | — |
 PRPH | $6M | -0.1 | — | — | -2.2% | -570.6% | -188.1% | -59.4% | — |
 HIMS | $7B | 55.4 | 46.5 | 98.7 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 COSM | $11M | -0.3 | — | — | 7.9% | -28.6% | -53.4% | -28.9% | — |
 NTRB | $46M | -1.5 | — | — | 25.7% | -408.4% | -125.6% | -270.2% | — |
 WRAP | $83M | -6.8 | — | — | 51.9% | -259.2% | -176.1% | -218.1% | — |
| Healthcare Median | — | 21.9 | 14.2 | 18.5 | 64.3% | -5.0% | -34.0% | -11.0% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 9 years · Updated daily
See NXGL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NXGL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NXGL vs LIQT
Side-by-side business, growth, and profitability comparison vs LiqTech International, Inc..
Start ComparisonNXGL — Frequently Asked Questions
Quick answers to the most common questions about buying NXGL stock.
What is NEXGEL, Inc.'s P/E ratio?
NEXGEL, Inc.'s current P/E ratio is -1.2x. This places it at the 50th percentile of its historical range.
What is NEXGEL, Inc.'s ROE?
NEXGEL, Inc.'s return on equity (ROE) is -58.3%. The historical average is -143.1%.
Is NXGL stock overvalued?
Based on historical data, NEXGEL, Inc. is trading at a P/E of -1.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are NEXGEL, Inc.'s profit margins?
NEXGEL, Inc. has 31.6% gross margin and -40.9% operating margin.